Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Devimistat + mFOLFIRINOX in Locally Advanced Pancreatic Cancer
NCT03699319Phase 2Completed
- Start
- Dec 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of devimistat in pancreatic ductal adenocarcinoma (PDAC). Started Dec 2018; status: completed.
02
Drugs
devimistat
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03699319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03699319.